
A Delaware district court jury has ruled in favour of Amgen in an ongoing dispute around patents for cholesterol-lowering drugs …

NICE has published draft guidance not recommending Sanofi/Regeneron’s Praluent (alirocumab) as an option for people with high cholesterol (primary hypercholesterolaemia …

The latest trials of the potentially blockbuster new heart drug alirocumab show it lowers cholesterol in people at moderate and …
Japanese pharma firm Shionogi & Co has opened a new office in London and pledged to expand into Europe. Osaka-based …

Merck has showcased its most promising drug candidates, and says it expects to make eight US filings in the next …